Market Outlook
The United States Autoimmune Disease Diagnostics Market was valued at USD 1.45 billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.02% through 2030. This growth trajectory reflects the increasing prevalence of autoimmune disorders, heightened awareness among healthcare providers and patients, and advancements in diagnostic technologies. The market is poised to benefit from a robust healthcare infrastructure, significant investment